- How is acute lymphocytic leukemia treated?
- Chemotherapy for acute lymphocytic leukemia
- Targeted therapy for acute lymphocytic leukemia
- Monoclonal antibodies to treat acute lymphoblastic leukemia
- Surgery for acute lymphocytic leukemia
- Radiation therapy for acute lymphocytic leukemia
- Stem cell transplant for acute lymphocytic leukemia
- Palliative treatment for acute lymphoblastic leukemia
- Clinical trials for acute lymphocytic leukemia
- Complementary and alternative therapies for acute lymphocytic leukemia
Targeted therapy for acute lymphocytic leukemia
In recent years, new drugs that target certain parts of cancer cells have been developed. These targeted therapies work differently from standard chemotherapy (chemo) drugs and often have different and less severe side effects.
Sometimes acute lymphocytic leukemia (ALL) cells have a certain gene change that is similar to the gene change seen in chronic myeloid leukemia (CML) cells. When they do have this gene change, some of the targeted drugs used to treat CML are useful in treating ALL. These drugs can help more ALL patients go into a remission and may help keep the leukemia from coming back.
A common side effect of targeted therapy drugs is swelling around the eyes or in the hands or feet. Other possible side effects include diarrhea, nausea, muscle pain, extreme tiredness (fatigue), and skin rashes, as well as lower red blood cell and platelet counts at the start of treatment.
Last Medical Review: 12/08/2014
Last Revised: 01/12/2015
- What Is Leukemia - Acute Lymphocytic (ALL) in Adults?
- Causes, Risk Factors, and Prevention
- Early Detection, Diagnosis, and Staging
- Treating Leukemia - Acute Lymphocytic (ALL) in Adults
- Talking With Your Doctor
- After Treatment
- What`s New in Leukemia - Acute Lymphocytic (ALL) in Adults Research?
- Other Resources and References